LXR/ApoE Activation Restricts Innate Immune Suppression in Cancer
Highlights •LXR agonism reduces immunosuppressive MDSC levels in mice and cancer patients •LXR transcriptional target ApoE impairs MDSC survival •LXR-induced MDSC depletion enhances activation of